Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (375 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 26 Mar 2024 – 20 Aug 2026, limited by HDFC NIFTY Realty Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | HDFC NIFTY Realty Index Fund | Nifty 500 |
|---|---|---|
| 26 Mar 2024 | ₹100.00 | ₹100.00 |
| 07 Jun 2024 | ₹120.28 | ₹108.79 |
| 19 Aug 2024 | ₹118.18 | ₹115.67 |
| 31 Oct 2024 | ₹112.46 | ₹113.42 |
| 12 Jan 2025 | ₹108.28 | ₹108.97 |
| 26 Mar 2025 | ₹95.74 | ₹106.35 |
| 08 Jun 2025 | ₹116.71 | ₹115.80 |
| 20 Aug 2025 | ₹102.75 | ₹115.69 |
| 01 Nov 2025 | ₹106.54 | ₹118.52 |
| 13 Jan 2026 | ₹96.39 | ₹117.37 |
| 27 Mar 2026 | ₹75.26 | ₹105.07 |
| 08 Jun 2026 | ₹84.06 | ₹110.84 |
| 20 Aug 2026 | ₹102.17 | ₹117.53 |
| Metric | HDFC · Direct NAV ₹10.21 Very High risk ★☆☆☆☆ 1Y | Category median Index Funds · 375 funds |
|---|---|---|
| -0.57% | +5.66% | |
| — | +8.82% | |
| — | +9.15% | |
| — | +11.72% | |
| +0.90% | +7.67% | |
| -0.56% | — | |
| — | +12.67% | |
| — | +13.64% | |
| — | +12.84% | |
| Risk | ||
| 28.01% | 13.97% | |
| -0.25 | 0.24 | |
| -0.35 | 0.36 | |
| -43.45% | -16.12% | |
| Nifty 500 | — | |
| — | +0.84% | |
| — | 1.00 | |
| — | 102.2% | |
| — | 97.2% | |
| 0.49% | 0.36% | |
| ₹66.14Cr | ₹177.09Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 30% | 35% | |
| Arun Agarwal | — | |
| 26 Mar 2024 | — | |
| 10 | — | |
| 100.0% | — | |
| 0.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.